新生儿侵袭性念珠菌病氟康唑治疗与预防的综述
Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates.
作者信息
Hornik Chi D, Bondi Deborah S, Greene Nicole M, Cober M Petrea, John Barnabas
出版信息
J Pediatr Pharmacol Ther. 2021;26(2):115-122. doi: 10.5863/1551-6776-26.2.115. Epub 2021 Feb 15.
Abstract
Invasive candidiasis accounts for approximately 10% of nosocomial infections in preterm infants, with an incidence of 1% to 4% among neonatal intensive care unit (NICU) admissions and a mortality as high as 20% to 30%. These outcomes warrant improved treatment and prevention strategies for infants at highest risk. The Infectious Diseases Society of America provides guidelines on antifungal medications for the prophylaxis and treatment of candidiasis in NICUs; however, there are still variations in practice on the use of fluconazole for prophylaxis and treatment of invasive candidiasis. This review provides specific information regarding fluconazole activity, pharmacokinetics, and a literature evaluation of dosing strategies and comparisons to other treatments in the neonatal population.
摘要
侵袭性念珠菌病约占早产儿医院感染的10%，在新生儿重症监护病房（NICU）收治的患儿中发病率为1%至4%，死亡率高达20%至30%。这些结果表明，需要改进针对高危婴儿的治疗和预防策略。美国传染病学会提供了关于在NICU中预防和治疗念珠菌病的抗真菌药物指南；然而，在使用氟康唑预防和治疗侵袭性念珠菌病方面，实际操作仍存在差异。本综述提供了有关氟康唑活性、药代动力学的具体信息，以及对新生儿人群给药策略的文献评估和与其他治疗方法的比较。
相似文献
1
Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates.
J Pediatr Pharmacol Ther. 2021;26(2):115-122. doi: 10.5863/1551-6776-26.2.115. Epub 2021 Feb 15.
2
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
Pediatrics. 2008 Apr;121(4):703-10. doi: 10.1542/peds.2007-1130.
3
"Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.
Early Hum Dev. 2012 May;88 Suppl 2:S45-9. doi: 10.1016/S0378-3782(12)70014-2.
4
Challenging issues in neonatal candidiasis.
Curr Med Res Opin. 2010 Jul;26(7):1769-78. doi: 10.1185/03007995.2010.487799.
5
Invasive Candida Infections in Neonatal Intensive Care Units: Risk Factors and New Insights in Prevention.
Pathogens. 2024 Aug 6;13(8):660. doi: 10.3390/pathogens13080660.
6
Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
Early Hum Dev. 2014 Mar;90 Suppl 1:S87-90. doi: 10.1016/S0378-3782(14)70026-X.
7
[Invasive candidiasis in neonatal intensive care units].
Arch Pediatr. 2011 May;18 Suppl 1:S22-32. doi: 10.1016/S0929-693X(11)70937-X.
8
Strategies to prevent invasive candidal infection in extremely preterm infants.
Clin Perinatol. 2010 Sep;37(3):611-28. doi: 10.1016/j.clp.2010.06.003.
9
Fluconazole prophylaxis for prevention of invasive candidiasis in infants.
Curr Opin Pediatr. 2014 Apr;26(2):151-6. doi: 10.1097/MOP.0000000000000060.
10
Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains.
Am J Perinatol. 2019 Jul;36(S 02):S126-S133. doi: 10.1055/s-0039-1691808. Epub 2019 Jun 25.
引用本文的文献
1
Addressing the silent threat: managing invasive infections in hospitalized newborns.
Front Pediatr. 2025 Jul 17;13:1613832. doi: 10.3389/fped.2025.1613832. eCollection 2025.
2
Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit.
Antibiotics (Basel). 2024 Dec 12;13(12):1209. doi: 10.3390/antibiotics13121209.
3
Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates.
Children (Basel). 2024 Sep 30;11(10):1207. doi: 10.3390/children11101207.
4
Usage of Antifungal Agents in Pediatric Patients Versus Adults: Knowledge and Gaps.
Mycopathologia. 2024 Sep 26;189(5):88. doi: 10.1007/s11046-024-00896-5.
5
Invasive Candida Infections in Neonatal Intensive Care Units: Risk Factors and New Insights in Prevention.
Pathogens. 2024 Aug 6;13(8):660. doi: 10.3390/pathogens13080660.
6
Obstructive Bilateral Renal Fungal Bezoars in an Extremely Premature Neonate Treated With Antifungals and Urokinase Irrigation: A Case Report and Review of the Literature.
Pediatr Infect Dis J. 2025 Jan 1;44(1):64-68. doi: 10.1097/INF.0000000000004505. Epub 2024 Aug 7.
7
Antibiotics, Analgesic Sedatives, and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative Review.
Children (Basel). 2024 Jul 18;11(7):871. doi: 10.3390/children11070871.
8
Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries.
Mycopathologia. 2024 Jun 28;189(4):60. doi: 10.1007/s11046-024-00867-w.
9
A Quality Improvement Project Aimed at Standardizing the Prescribing of Fluconazole Prophylaxis in a Level IV Neonatal Intensive Care Unit.
Pediatr Qual Saf. 2022 Jul 18;7(4):e579. doi: 10.1097/pq9.0000000000000579. eCollection 2022 Jul-Aug.
10
Evaluation of the mannan antigen assay in neonates with or without Candida albicans colonization.
Med Mycol. 2024 Jan 27;62(2). doi: 10.1093/mmy/myad138.
本文引用的文献
1
Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
J Antimicrob Chemother. 2018 Dec 1;73(12):3482-3487. doi: 10.1093/jac/dky353.
2
Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
Br J Clin Pharmacol. 2018 Sep;84(9):1989-1999. doi: 10.1111/bcp.13628. Epub 2018 Jun 21.
3
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996.
4
Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis.
J Pediatr. 2017 Jun;185:129-135.e6. doi: 10.1016/j.jpeds.2017.02.039. Epub 2017 Mar 10.
5
Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5539-45. doi: 10.1128/AAC.00963-16. Print 2016 Sep.
6
Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.
Clin Infect Dis. 2016 Sep 1;63(5):604-10. doi: 10.1093/cid/ciw363. Epub 2016 Jun 13.
7
Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study.
BMC Pediatr. 2016 May 16;16:67. doi: 10.1186/s12887-016-0605-y.
8
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
9
Neonatal candidiasis: diagnosis, prevention, and treatment.
J Infect. 2014 Nov;69 Suppl 1(0 1):S19-22. doi: 10.1016/j.jinf.2014.07.012. Epub 2014 Aug 13.
10
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
Clin Pharmacokinet. 2014 Jul;53(7):581-610. doi: 10.1007/s40262-014-0147-0.
Zotero 插件